Science & Technology
Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis
Department of Health and Human Services — National Institutes of Health
Opportunity #: 4R42DK141379-02
Award Ceiling
$664K
Award Floor
$664K
Close Date
Aug 31, 2028
900 days leftTotal Funding
$664K
Expected Awards
1
Posted Date
Sep 1, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-4R42DK141379-02
Description
STTR Phase Phase II award: "Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis" awarded to Faknostics, LLC in Phoenix, Arizona. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $663,777. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.